Our study revealed pseudopterosin to efficaciously inhibit NF-κB signaling and subsequent cytokine release in both THP-1 monocytic leukemia cells and MDA-MB-231 breast cancer cells. This evidence concerns the gene NFKB1 and breast carcinoma.